[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5216 Introduced in House (IH)]
<DOC>
114th CONGRESS
2d Session
H. R. 5216
To provide funding for opioid and heroin abuse prevention and
treatment, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 12, 2016
Mr. Ben Ray Lujan of New Mexico (for himself, Mr. Cummings, Ms. Roybal-
Allard, Mr. Kennedy, Mr. Kilmer, Ms. Kuster, Mr. Hastings, Mrs.
Napolitano, Mr. Tonko, Ms. Matsui, Mr. Neal, Mr. Grayson, Ms. Norton,
Mr. Keating, Ms. Michelle Lujan Grisham of New Mexico, Mr. Blumenauer,
Mr. Levin, Mr. Clay, Mr. Larsen of Washington, Ms. Edwards, Ms. Kaptur,
Ms. Jackson Lee, Mrs. Capps, Mr. Lynch, Mr. Norcross, Mrs. Lawrence,
Mr. Meeks, Mr. Sean Patrick Maloney of New York, Ms. Speier, Mr.
Quigley, Mr. Gutierrez, Mr. Welch, Mr. Ruppersberger, Mr. Connolly, Mr.
McGovern, Mr. Loebsack, Mr. Sarbanes, Ms. Brown of Florida, Mrs.
Dingell, Mr. Kind, Mr. Israel, Mr. Pascrell, Mr. Gallego, Mr. Capuano,
Mr. Courtney, Mr. Beyer, Mr. Thompson of Mississippi, Mr. Jeffries, Mr.
Yarmuth, Mr. Cardenas, Mr. Sires, Mr. Kildee, Ms. Eshoo, Mr. Gene Green
of Texas, Mr. Vargas, Ms. Bass, Ms. Clarke of New York, Mr. Van Hollen,
Ms. Clark of Massachusetts, Mr. Cohen, Ms. Tsongas, Ms. Fudge, Mr.
Aguilar, Mr. Ted Lieu of California, Mr. Richmond, Mr. Swalwell of
California, Mr. Lewis, Mr. Heck of Washington, Ms. McCollum, Ms.
Duckworth, Mr. Johnson of Georgia, Mr. Ryan of Ohio, Mr. Delaney, Ms.
Esty, Mr. Conyers, Mr. DeFazio, Mr. Al Green of Texas, Mr. Larson of
Connecticut, Mr. Butterfield, Mr. Danny K. Davis of Illinois, Ms.
Plaskett, Ms. Lee, Ms. Loretta Sanchez of California, Mr. Brendan F.
Boyle of Pennsylvania, Mr. Ruiz, Ms. Titus, Ms. Brownley of California,
Mr. Moulton, Ms. DeLauro, Mr. Honda, and Mr. Peterson) introduced the
following bill; which was referred to the Committee on Energy and
Commerce, and in addition to the Committees on the Judiciary and the
Budget, for a period to be subsequently determined by the Speaker, in
each case for consideration of such provisions as fall within the
jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To provide funding for opioid and heroin abuse prevention and
treatment, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Opioid and Heroin Abuse Crisis
Investment Act of 2016''.
SEC. 2. FUNDING FOR OPIOID AND HEROIN ABUSE PREVENTION AND TREATMENT.
(a) Funding.--There are authorized to be appropriated, and are
appropriated, out of monies in the Treasury not otherwise obligated,
$1,164,600,000 for the period of fiscal years 2017 and 2018, to improve
opioid prescribing practices and expand access to substance use
treatment and to reduce opioid use disorders and overdose, to be made
available in accordance with this Act and the amendments made by this
Act.
(b) State Targeted Response Cooperative Agreements.--Subpart 1 of
part B of title V of the Public Health Service Act (42 U.S.C. 290bb et
seq.) is amended by inserting after section 509 the following:
``SEC. 510. STATE TARGETED RESPONSE COOPERATIVE AGREEMENTS.
``(a) In General.--The Secretary shall enter into additional
targeted response cooperative agreements with States under this title
to expand opioid treatment capacity and make services more affordable
to those who cannot afford such services.
``(b) Awarding of Funding.--The Secretary shall allocate funding to
States under this section based on--
``(1) the severity of the opioid epidemic in the State; and
``(2) the strength of the strategy of the State to respond
to such epidemic.
``(c) Use of Funds.--Amounts received by a State under this section
shall be used to expand treatment capacity and make services more
affordable to those who cannot afford such services and to help
individuals seek treatment, successfully complete treatment, and
sustain recovery.
``(d) Funding.--From amounts appropriated under section 2(a) of the
Opioid and Heroin Abuse Crisis Investment Act, $465,000,000 is
available to carry out this section for each of fiscal years 2017 and
2018.''.
(c) Treatment for Prescription Drug Abuse and Heroin Use.--Section
331(b) of the Public Health Service Act (42 U.S.C. 254d(b)) is amended
by adding at the end the following:
``(3)(A) The Secretary shall use amounts made available under
subparagraph (B) to support enhanced loan repayment awards to increase
the number of clinicians in the Corps with medication-assisted
treatment training to treat individuals with opioid use disorders
through loan repayments to clinicians.
``(B) From amounts appropriated under section 2(a) of the Opioid
and Heroin Abuse Crisis Investment Act, $25,000,000 is available to
carry out this paragraph for each of fiscal years 2017 and 2018.''.
(d) Evaluation of Medication-Assisted Treatment.--Subpart 1 of part
B of title V of the Public Health Service Act (42 U.S.C. 290bb et seq.)
is amended by inserting after section 510, as added by subsection (b),
the following:
``SEC. 511. EVALUATION OF MEDICATION-ASSISTED TREATMENT.
``(a) In General.--In order to assess the treatment outcomes of
patients with opioid addiction receiving medication-assisted treatment,
the Secretary shall evaluate the short-, medium-, and long-term
outcomes of such substance abuse treatment programs in order to
increase effectiveness in reducing opioid use disorders, overdose, and
death.
``(b) Funding.--From amounts appropriated under section 2(a) of the
Opioid and Heroin Abuse Crisis Investment Act, $15,000,000 is available
to carry out this section for each of fiscal years 2017 and 2018.''.
(e) Medication-Assisted Treatment for Prescription Drug and Opioid
Addiction.--Section 509 of the Public Health Service Act (42 U.S.C.
290bb-2) is amended--
(1) by redesignating subsection (f) as subsection (g); and
(2) by inserting after subsection (e), the following:
``(f) Medication-Assisted Treatment for Prescription Drug and
Opioid Addiction.--
``(1) In general.--In carrying out this section, the
Secretary shall use amounts made available under paragraph (3)
to award grants to States to expand or enhance medication-
assisted treatment utilizing medications approved by the Food
and Drug Administration in combination with psychosocial
services, recovery support services, and coordination with HIV
or hepatitis C direct services.
``(2) Funding.--From amounts appropriated under section
2(a) of the Opioid and Heroin Abuse Crisis Investment Act,
$50,100,000 is available to carry out this subsection for
fiscal year 2017.''.
(f) Dissemination of Guidelines for Preventing Prescription Drug
Overdose.--Section 317 of the Public Health Service Act (42 U.S.C.
247b) is amended by adding at the end the following:
``(n) Dissemination of Guidelines for Preventing Prescription Drug
Overdose.--
``(1) In general.--The Director of the Centers for Disease
Control and Prevention shall disseminate guidelines to improve
opioid prescribing practices to reduce opioid use disorders and
overdose.
``(2) Use of funds.--In carrying out this subsection, the
Director of the Centers for Disease Control and Prevention
shall use amounts made available under paragraph (3) to--
``(A) pilot test, evaluate, and adapt comprehensive
tools and dissemination strategies to convey opioid
prescribing guidelines of the Centers for Disease
Control and Prevention in succinct, usable formats
accessible to health care providers;
``(B) develop, evaluate, and publicly disseminate
clinical decision support tools derived from the opioid
prescribing guidelines of the Centers for Disease
Control and Prevention;
``(C) establish training modules in partnership
with professional societies and health systems,
including online modules available for continuing
medical education credits and maintenance of
certification; and
``(D) coordinate with Office of the National
Coordinator for Health Information Technology to ensure
that guidelines developed under this subsection are
effectively disseminated and translated into clinical
support tools for integration into clinical workflow.
``(3) Funding.--From amounts appropriated under section
2(a) of the Opioid and Heroin Abuse Crisis Investment Act,
$10,000,000 is available to carry out this subsection for
fiscal year 2017.''.
(g) Rural Opioid Overdose Reversal Grant Program.--Section 330A of
the Public Health Service Act (42 U.S.C. 254c) is amended--
(1) by redesignating subsection (j) as subsection (k); and
(2) by inserting after subsection (i), the following:
``(j) Rural Opioid Overdose Reversal Grant Program.--
``(1) In general.--The Director may award grants to
eligible entities to implement activities for the prevention,
intervention, and treatment of opioid misuse and overdose.
``(2) Eligibility.--To be eligible to receive a grant under
this subsection, an entity--
``(A) shall be a rural public or rural nonprofit
private entity; and
``(B) shall represent a network composed of
participants--
``(i) that include 3 or more health care
providers; and
``(ii) that may be nonprofit or for-profit
entities.
``(3) Use of funds.--Amounts awarded under a grant under
this subsection shall be used--
``(A) to provide opioid misuse education and
prevention services;
``(B) to provide training to licensed health care
professionals and first responders in the recognition
of the signs of opioid overdose and learn the
appropriate way to administer naloxone;
``(C) to provide appropriate transportation
services to a hospital or clinic for continued care
after administration;
``(D) to refer those individuals with a drug
dependency to an appropriate substance use disorder
treatment centers where care coordination is provided
by a team of providers; and
``(E) to purchase naloxone and opioid overdose
reversal devices.
``(4) Funding.--From amounts appropriated under section
2(a) of the Opioid and Heroin Abuse Crisis Investment Act,
$10,000,000 is available to carry out this subsection for
fiscal year 2017.''.
(h) Prescription Drug Overdose Initiative.--Section 3001(c) of the
Public Health Service Act (42 U.S.C. 300jj-11(c)) is amended by adding
at the end the following:
``(9) Prescription drug overdose initiative.--
``(A) In general.--The Secretary, acting through
the National Coordinator, shall use amounts made
available under subparagraph (B) to expand efforts to
harmonize technical standards to support prescription
drug monitoring programs and health information
technology interoperability.
``(B) Funding.--From amounts appropriated under
section 2(a) of the Opioid and Heroin Abuse Crisis
Investment Act, $5,000,000 is available to carry out
this paragraph for fiscal year 2017.''.
(i) Bureau of Prisons Treatment Programs.--Section 4042 of title
18, United States Code, is amended by adding at the end the following:
``(e) Treatment Programs.--
``(1) In general.--The Director of the Bureau of Prisons
shall use amounts made available under paragraph (2) to support
drug treatment programs within the Bureau of Prisons, including
expanding the medication-assisted treatment pilot.
``(2) Funding.--From amounts appropriated under section
2(a) of the Opioid and Heroin Abuse Crisis Investment Act,
$3,000,000 is available to carry out this subsection for fiscal
year 2017.''.
(j) Second Chance Act of 2007.--Section 201 of the Second Chance
Act of 2007 (42 U.S.C. 17521) is amended--
(1) by redesignating subsection (f) as subsection (g); and
(2) by inserting after subsection (e), the following:
``(f) Community Reintegration.--
``(1) In general.--The Attorney General shall use amounts
made available under paragraph (2) to carry out activities to
reduce recidivism and increase public safety by helping
justice-involved individuals successfully reintegrate into the
community, including by carrying out activities including
providing treatment for co-occurring disorders and providing
family-based substance abuse treatment.
``(2) Funding.--From amounts appropriated under section
2(a) of the Opioid and Heroin Abuse Crisis Investment Act,
$50,000,000 is available to carry out this subsection for
fiscal year 2017.''.
(k) Residential Substance Abuse Treatment.--Section 503 of the
Controlled Substances Act (21 U.S.C. 873) is amended by adding at the
end the following:
``(e)(1) In carrying out this section, the Attorney General may use
amounts made available under paragraph (2) to provide support for
State, local, and tribal governments in the development of residential
and aftercare services for substance-involved inmates.
``(2) From amounts appropriated under section 2(a) of the Opioid
and Heroin Abuse Crisis Investment Act, $14,000,000 is available to
carry out this section for fiscal year 2017.''.
(l) Heroin Enforcement Groups.--Part E of the Controlled Substances
Act (21 U.S.C. 871 et seq.) is amended by adding at the end the
following:
``SEC. 521. HEROIN ENFORCEMENT GROUPS.
``(a) In General.--The Attorney General shall use amounts made
available under subsection (b) to establish new heroin enforcement
groups within the Drug Enforcement Administration to target, disrupt,
and dismantle heroin trafficking organizations.
``(b) Funding.--From amounts appropriated under section 2(a) of the
Opioid and Heroin Abuse Crisis Investment Act, $12,500,000 is available
to carry out this section for fiscal year 2017.''.
(m) Emergency Designation.--The amounts made available by this Act
are designated as an emergency requirement pursuant to section 4(g) of
the Statutory Pay-As-You-Go Act of 2010 (2 U.S.C. 933(g)).
<all>